Status:
COMPLETED
Diabetes Education and A1c Study
Lead Sponsor:
Michigan State University
Collaborating Sponsors:
Blue Cross Blue Shield Foundation of Michigan
Conditions:
Diabetes Mellitus, Type 2
Sleep
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Sleep problems are associated with poor blood glucose control, but current diabetes self-management programs do not include sleep education. This study will randomize participants into two groups: one...
Eligibility Criteria
Inclusion
- Individuals with a diagnosis of type 2 diabetes who are patients at the Michigan State University (MSU) Endocrinology clinic,
- a diagnosis of overweight or obesity (Body Mass Index greater than or equal to 25.0 kg/m2),
- the most recent hemoglobin A1c value greater than or equal to 7.5%, and
- the ability to attend online program sessions.
Exclusion
- significant psychiatric disorders,
- advanced medical conditions that require alterations to the MNT for DM2, e.g., advanced chronic kidney disease, and
- an inability to follow recommendations due to cognitive deficits.
Key Trial Info
Start Date :
March 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2022
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04806685
Start Date
March 15 2021
End Date
October 1 2022
Last Update
December 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Michigan State University
East Lansing, Michigan, United States, 48824